GlobeNewswire Inc.··NaBeam Therapeutics to Unveil 2025 Results and Novel Liver Disease Program
Beam Therapeutics will discuss 2025 results and unveil a new liver disease program on February 24, 2026. The company also secured FDA alignment for accelerated approval of BEAM-302.
BEAMFDA approvalbase editing